Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (46 quarters reported)
$738M in Q2 2013 → $48.1M now. Hover for any quarter.
As reported for the quarter ended September 30, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Exelixis Inc | 73.4% | Trimmed 22% | 1,362,450 | $35.4M |
| Esperion Therapeutics Inc | 13.0% | Unchanged | 3,791,300 | $6.26M |
| IM Ishares Msci India ETF | 7.2% | Unchanged | 59,400 | $3.47M |
| WI Wisdomtree India Earnings Fund | 6.4% | Unchanged | 60,700 | $3.06M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2024 · filed October 07, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −390,550 | −$10.1M | 73.4% |
quarter ended June 30, 2024 · filed July 22, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −445,800 | −$10M | 72.9% |
quarter ended March 31, 2024 · filed April 11, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −439,500 | −$10.4M | 76.7% |
quarter ended December 31, 2023 · filed January 04, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −499,900 | −$12M | 79.1% |
quarter ended September 30, 2023 · filed October 31, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −1,997,558 | −$43.6M | 88.9% |
| WI Wisdomtree India Earnings Fund | Trimmed | −91,100 | −$3.35M | 2.9% |
| IM Ishares Msci India ETF | Trimmed | −69,800 | −$3.09M | 3.4% |
| Esperion Therapeutics Inc | Trimmed | −611,673 | −$599K | 4.8% |
quarter ended June 30, 2023 · filed July 25, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −277,142 | −$5.3M | 85.2% |
| WI Wisdomtree India Earnings Fund | Trimmed | −62,000 | −$2.16M | 4.6% |
| IM Ishares Msci India ETF | Trimmed | −42,000 | −$1.84M | 4.9% |
quarter ended March 31, 2023 · filed April 10, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −1,192,286 | −$23.1M | 83.7% |
| Esperion Therapeutics Inc | Trimmed | −65,862 | −$105K | 5.6% |
quarter ended December 31, 2022 · filed January 05, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Exelixis Inc | Trimmed | −211,114 | −$3.39M | 71.6% |
Loading...
